Merck and InnoCore aim to improve patient compliance

The sustained release technology for systemic and site-specific parenteral drug delivery will allow the development of injectable biological formulations with conserved bioactivity

picture of

Breaking News

Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharmapack 2019

Aptar Pharma, a leading drug delivery systems provider, will once again be a major exhibitor at Pharmapack 2019, which ...

Commercial opportunities for emerging infectious diseases vaccine developers

Although development of interventions for emerging infectious diseases (EIDs) has traditionally been limited by a lack ...

Second failure of AstraZenecaís Imfinzi + tremelimumab combination significant setback says GlobalData

Following the news (Friday 7 December) that the combination did not improve overall survival versus standard-of-care ...

A perfect match for tablets

The multifunctional mineral excipient Omyapharm provides oral dosage forms with excellent processing properties

Nemera organises an expert review on the present and future of inhalation products

Respiratory diseases still impact the everyday life of many people

Catapult and MRC unite to advance human-based drug evaluation

Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the ...

The race to be first: drug delivery systems for biosimilars

For biosimilar manufacturers, the market potential is significant, especially for those that are first to market

Pancreatic cancer treatment heads in promising direction, says GlobalData

Despite the disappointing history of drug development in pancreatic cancer, the therapeutic pipeline and clinical ...

PIVOTAL trial confirms long-term safety and efficacy of IV iron dosing

The long-term safety and efficacy of intravenous iron dosing has been confirmed allowing higher Ferritin concentration ...

Connecting the dots in digital health

In this feature, Phillips-Medisize, a Molex company, looks at the potential of smart devices and connected health ...

Moving the needle in 2019

By now, says 3Mís Dr Steven Wick, itís no secret that technological advances are changing the landscape of drug delivery

A multifunctional mineral excipient at CPhI 2018

Omyapharm provides tablets and granules with excellent compactability, mechanical stability and absorption capacity

Cambrex upgrades generic API manufacturing facilities in Milan

The $3m investment will include the installation of a new 12,000 litre reactor, as well as reconfiguration of the ...